Related Experiment Video
Updated: Oct 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Uncovering hidden druggable sites: computational approaches to allosteric and cryptic pocket discovery-from molecular
Sirish Kaushik Lakkaraju1, Olivia Pierce2, Ahmet Mentes3
1Computational Sciences, Bristol Myers Squibb, Princeton, NJ, 08540, USA. kaushik.lakkaraju@bms.com.
Abstract:
Allosteric and cryptic binding pockets represent a vast underexploited frontier in drug discovery, offering routes to biological targets historically considered undruggable. The absence of apparent binding pockets in the global conformations of apo structures, together with limitations in availability of chemical probes and experimental structures for novel targets, makes the identification of allosteric and cryptic sites particularly challenging. Despite their ability to reveal transient and otherwise inaccessible pockets, computational methods remain underutilized for allosteric and cryptic site discovery. In this perspective, we present the current state-of-the-art of computational strategies that are available in a computational scientists' toolbox to evaluate the possibility of finding such pockets when assessing a new target in a drug discovery project. Computational approaches span a spectrum from physics-based methods grounded in molecular thermodynamics to AI/ML techniques for identifying allosteric and cryptic binding sites. Physics-based approaches encompass methods operating across multiple scales, from single-conformation analyses that identify pockets based on geometry and energetics (e.g., Fpocket, SiteMap) to molecular simulations that reveal cryptic states and transient binding sites, as well as mixed-solvent and probe-based approaches (e.g., SILCS, MixMD) that delineate druggable hotspots through enhanced sampling. AI/ML methods such as PocketMiner and deep learning cofolding models (AlphaFold3, Boltz) that rapidly predict cryptic sites are discussed in the context of them being over 1,000-fold faster than classical simulations. By surveying current methods and benchmark studies, we aim to define their domains of applicability, highlight their strengths and limitations, and identify opportunities for their integration in prospective drug discovery.
Related Concept Videos
Drug Discovery: Overview
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding and Linkage
